Haematologica (Apr 2019)

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms

  • Anna B. Halpern,
  • Megan Othus,
  • Emily M. Huebner,
  • Bart L. Scott,
  • Paul C. Hendrie,
  • Mary-Elizabeth M. Percival,
  • Pamela S. Becker,
  • Heather A. Smith,
  • Vivian G. Oehler,
  • Johnnie J. Orozco,
  • Ryan D. Cassaday,
  • Kelda M. Gardner,
  • Tara L. Chen,
  • Sarah A. Buckley,
  • Kaysey F. Orlowski,
  • Asma Anwar,
  • Elihu H. Estey,
  • Roland B. Walter

DOI
https://doi.org/10.3324/haematol.2018.204792
Journal volume & issue
Vol. 104, no. 4

Abstract

Read online

No abstracts available.